These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29655371)

  • 21. Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.
    Di Filippo M; Pini LA; Pelliccioli GP; Calabresi P; Sarchielli P
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1224-9. PubMed ID: 18535023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis.
    Rossi S; Studer V; Motta C; Germani G; Macchiarulo G; Buttari F; Mancino R; Castelli M; De Chiara V; Weiss S; Martino G; Furlan R; Centonze D
    J Neuroinflammation; 2014 Feb; 11():32. PubMed ID: 24548694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.
    Rossi S; Furlan R; De Chiara V; Motta C; Studer V; Mori F; Musella A; Bergami A; Muzio L; Bernardi G; Battistini L; Martino G; Centonze D
    Ann Neurol; 2012 Jan; 71(1):76-83. PubMed ID: 22275254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis.
    Stampanoni Bassi M; Gilio L; Iezzi E; Moscatelli A; Pekmezovic T; Drulovic J; Furlan R; Finardi A; Mandolesi G; Musella A; Galifi G; Fantozzi R; Bellantonio P; Storto M; Centonze D; Buttari F
    Front Aging Neurosci; 2021; 13():694651. PubMed ID: 34566620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.
    Scalabrino G; Galimberti D; Mutti E; Scalabrini D; Veber D; De Riz M; Bamonti F; Capello E; Mancardi GL; Scarpini E
    Brain Res; 2010 May; 1333():64-71. PubMed ID: 20347721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical plasticity predicts recovery from relapse in multiple sclerosis.
    Mori F; Kusayanagi H; Nicoletti CG; Weiss S; Marciani MG; Centonze D
    Mult Scler; 2014 Apr; 20(4):451-7. PubMed ID: 24263385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
    Ferraro D; Galli V; Vitetta F; Simone AM; Bedin R; Del Giovane C; Morselli F; Filippini MM; Nichelli PF; Sola P
    J Neuroimmunol; 2015 Jun; 283():64-9. PubMed ID: 26004159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
    Calabrese M; Federle L; Bernardi V; Rinaldi F; Favaretto A; Varagnolo MC; Perini P; Plebani M; Gallo P
    Mult Scler; 2012 Feb; 18(2):174-80. PubMed ID: 21868488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between the levels and variation of CXCL12, PDGF, CXCL14 in cerebrospinal fluid of optic neuritis and neuromyelitis optica].
    Jiang Z; Wei S; Liu Z; Li H; Chen T
    Zhonghua Yan Ke Za Zhi; 2015 Dec; 51(12):901-6. PubMed ID: 26888271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.
    Negrotto L; Farez MF; Correale J
    JAMA Neurol; 2016 May; 73(5):520-8. PubMed ID: 26953870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) levels in the cerebrospinal fluid of children with influenza-associated encephalopathy.
    Morichi S; Morishita N; Takeshita M; Ishida Y; Oana S; Yamanaka G; Kashiwagi Y; Kawashima H
    J Infect Chemother; 2017 Feb; 23(2):80-84. PubMed ID: 27887787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.
    Mori F; Nisticò R; Nicoletti CG; Zagaglia S; Mandolesi G; Piccinin S; Martino G; Finardi A; Rossini PM; Marfia GA; Furlan R; Centonze D
    Mult Scler; 2016 Oct; 22(11):1405-1412. PubMed ID: 26733422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients.
    Sarchielli P; Di Filippo M; Ercolani MV; Chiasserini D; Mattioni A; Bonucci M; Tenaglia S; Eusebi P; Calabresi P
    Neurosci Lett; 2008 Apr; 435(3):223-8. PubMed ID: 18353554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
    Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E
    J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J; Petzold A; Junker A; Tumani H
    Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis.
    Voortman MM; Damulina A; Pirpamer L; Pinter D; Pichler A; Enzinger C; Ropele S; Bachmaier G; Archelos JJ; Marsche G; Khalil M
    Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572477
    [No Abstract]   [Full Text] [Related]  

  • 40. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.